載入...
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer
Targeting mutated oncogenes is an effective approach for treating cancer. The 4 main driver genes of pancreatic ductal adenocarcinoma (PDAC) are KRAS, TP53, CDKN2A, and SMAD4, collectively called the “big 4” of PDAC, however they remain challenging therapeutic targets. In this study, ArfGAP with SH3...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019229/ https://ncbi.nlm.nih.gov/pubmed/33605496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14858 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|